BioHealth News Archive
NIH Awards MicroGEM up to $40.9M to Fast-Track Rapid, No-Lab COVID-19 Saliva Test
CHARLOTTESVILLE, Va., Sept. 2, 2020 /PRNewswire/ -- MicroGEM today announced it has been awarded up to $40.9 million by the National Institutes of Health (NIH),…
Read More
AstraZeneca Launches 30,000-Patient Phase III U.S. Trial of COVID-19 Vaccine
AstraZeneca said today it has launched a 30,000-patient Phase III trial in the U.S. of AZD1222, the COVID-19 vaccine it is co-developing with the…
Read More
California developer Alexandria Real Estate proposes office, lab building at Baltimore’s Port Covington – Baltimore Business Journal
The 170,000-square-foot building would be located near Rye Street Tavern. {iframe}https://www.bizjournals.com/baltimore/news/2020/09/01/alexandria-proposes-port-covington-building.html{/iframe}
Read More
Johnson & Johnson Innovation and BARDA Select a Surge Force of Companies with the Aim to Combat the COVID-19 Pandemic as Part of Its BLUE KNIGHT™ Collaboration – News | JLABS
WASHINGTON, D.C., August 27, 2020 - Johnson & Johnson Innovation LLC today announced the first companies to be part of its medical countermeasure innovation…
Read More
American Gene Technologies Gets Go-Ahead to Test Possible HIV Cure | BioSpace
HIV therapies, typically cocktails of antiviral drugs, have proven to be very successful in controlling HIV/AIDS. However, they are not a “cure,” which is…
Read More
Emergent BioSolutions Teams Up with Boston Red Sox, Cincinnati Reds, Philadelphia Phillies, and MAPDA to Highlight Importance of Overdose Reversal Medicines on International Overdose Awareness Day | BioSpace
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it is teaming up with the Boston Red…
Read More
Development of COVID-19 vaccine AZD1222 expands into US Phase III clinical trial across all adult age groups – Vaccitech
Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces that the development of AstraZeneca’s AZD1222 vaccine…
Read More
Jonathan DeCarlo Named Chief Financial Officer at Emmes
ROCKVILLE, Md., Sept. 1, 2020 /PRNewswire/ -- Emmes today announced that Jonathan DeCarlo has been promoted to chief financial officer. DeCarlo, who has served as…
Read More
Johns Hopkins University Giving Wellness Kits To Undergrads To Protect Against COVID-19 – CBS Baltimore
BALTIMORE (WJZ) — As the fall semester begins, Johns Hopkins University wants to make sure its students are protected. They are giving out wellness…
Read More
ITI Announces Publication of Results from 3 ATTAC Studies of CMV-Specific Dendritic Cell Vaccines for the Treatment of GBM – Immunomic Therapeutics
ROCKVILLE, Md. & SAN DIEGO–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced today…
Read More
5th Annual BioHealth Capital Region (BHCR) Crab Trap Competition
Don't miss your change to be named the BioHealth Startup with the Most Commectial Potential at the BHCR Forum, win $10,000 and more! …
Read More
Unique Team-Building and Promotion for your BioHealth Company: FRAXA Biotech Games™ for Research – Register Now. Games Begin This Thursday Sept. 10th
Are you seeking an opportunity to engage your firm in a fun community-building activity? Register one or more teams for the FRAXA Biotech Games. …
Read More
Cartesian Therapeutics Initiates Clinical Trial of First RNA-Engineered Cell Therapy for Acute Respiratory Distress Syndrome and COVID-19 – Cartesian
Gaithersburg, MD, September 1, 2020 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, autoimmune diseases and…
Read MoreOxiWear rushes to get wearable oxygen monitor to Covid-19 patients – Washington Business Journal
OxiWear's own founder is a user herself of its oxygen monitor for patients with severe pulmonary hypertension. Image: Shavini Fernando is founder and CEO…
Read More
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, Joins Rich Bendis on BioTalk
Economic Alliance of Greater Baltimore (EAGB), President and CEO, Michele L. Whelley, joins BioTalk to discuss her career, the economic development environment in Baltimore,…
Read More